glp-1 and dpp4 PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: Design principles of long-acting DPP-4

But safeguards can prevent these risks: targeted financial support, scrutiny from the competition watchdog, and a better system to measure pharmacy quality

Each film-coated tablet of JANUVIA contains 32.13, 64.25, or 128.5 mg of sitagliptin phosphate monohydrate, which is equivalent to 25, 50, or 100 mg, respectively, of free base and the following inactive ingredients: microcrystalline cellulose, anhydrous dibasic calcium phosphate, croscarmellose sodium, magnesium stearate, sodium stearyl fumarate, and propyl gallate

London: BMJ Group and Pharmaceutical Press

This allows it to operate with a leaner structure and pass those savings on to patients

Homeostatic control of water balance